Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-793P encodes a pseudogene derived from the U6 small nuclear RNA gene family and is located on chromosome 6 (6p23, 14,646,535-14,646,638)[1][3][7][8]. As a pseudogene, it does not encode a functional protein or active small nuclear RNA; instead, it is considered a vestigial, non-functional genetic element formed by gene duplication or retrotransposition events[2][7]. While some pseudogenes can have regulatory roles—for example, modulating the expression of related genes via RNA-mediated mechanisms—the specific function of RNU6-793P remains uncharacterized, and there is currently no evidence that it acts as a therapeutic target, biomarker, or disease driver[2][7][8]. Summary: RNU6-793P does not encode a functional product and is not a receptor, enzyme, or target for any approved drugs. It is classified as a small nuclear RNA pseudogene, and while pseudogenes can play regulatory roles in general, there is no evidence for such activity or disease association specific to RNU6-793P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 793, pseudogene (RNU6-793P).